肌营养不良症的诊断、发病机制与治疗
Diagnosis, Pathogenesis and Treatment of Muscular Dystrophy.
作者信息
Bozzi Manuela
机构信息
Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Roma, Italy.
Istituto di Scienze e Tecnologie Chimiche "Giulio Natta"-SCITEC (CNR), Largo F. Vito 1, 00168 Roma, Italy.
出版信息
Biomedicines. 2025 Jul 25;13(8):1820. doi: 10.3390/biomedicines13081820.
Abstract
Muscular dystrophies are a group of inherited genetic disorders that involve an ever-growing number of genes [...].
摘要
肌肉萎缩症是一组遗传性基因疾病，涉及越来越多的基因[...]。
相似文献
1
Diagnosis, Pathogenesis and Treatment of Muscular Dystrophy.肌营养不良症的诊断、发病机制与治疗
Biomedicines. 2025 Jul 25;13(8):1820. doi: 10.3390/biomedicines13081820.
3
Atypical Presentation of Congenital Muscular Dystrophy: A LAMA2 Related Muscular Dystrophy.先天性肌营养不良的非典型表现：一种与LAMA2相关的肌营养不良
J Child Neurol. 2025 Sep;40(8):674-677. doi: 10.1177/08830738251333467. Epub 2025 Apr 29.
4
A Review of Muscular Dystrophies.肌肉萎缩症综述。
Anesth Prog. 2024 May 3;71(1):44-52. doi: 10.2344/673191.
6
An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases.外显子跳跃和剪接调控在肌肉萎缩症及多种遗传疾病中的最新进展与临床应用概述
Methods Mol Biol. 2025;2964:53-83. doi: 10.1007/978-1-0716-4730-1_3.
10
Muscular Dystrophies.肌肉萎缩症
Adv Exp Med Biol. 2025;1478:245-284. doi: 10.1007/978-3-031-88361-3_11.
本文引用的文献
1
Advances in Duchenne Muscular Dystrophy: Diagnostic Techniques and Dystrophin Domain Insights.杜兴氏肌肉营养不良症的进展：诊断技术与肌营养不良蛋白结构域见解
Int J Mol Sci. 2025 Apr 10;26(8):3579. doi: 10.3390/ijms26083579.
2
Clinical applications of exon-skipping antisense oligonucleotides in neuromuscular diseases.外显子跳跃反义寡核苷酸在神经肌肉疾病中的临床应用
Mol Ther. 2025 Jun 4;33(6):2689-2704. doi: 10.1016/j.ymthe.2025.04.038. Epub 2025 Apr 30.
3
Deciphering Facioscapulohumeral Dystrophy in the clinical trials era: where are we now?在临床试验时代解读面肩肱型肌营养不良症：我们目前处于什么阶段？
Acta Myol. 2025 Mar;44(1):2-10. doi: 10.36185/2532-1900-1047.
4
The road toward AAV-mediated gene therapy of Duchenne muscular dystrophy.杜兴氏肌肉营养不良症的腺相关病毒介导基因治疗之路。
Mol Ther. 2025 May 7;33(5):2035-2051. doi: 10.1016/j.ymthe.2025.03.065. Epub 2025 Apr 2.
5
The 2025 version of the gene table of neuromuscular disorders (nuclear genome).
Neuromuscul Disord. 2025 Jan;46:105261. doi: 10.1016/j.nmd.2024.105261. Epub 2024 Dec 9.
6
Oxidative Stress, Inflammation and Connexin Hemichannels in Muscular Dystrophies.氧化应激、炎症与肌营养不良中的连接蛋白半通道
Biomedicines. 2022 Feb 21;10(2):507. doi: 10.3390/biomedicines10020507.
7
Casimersen: First Approval.卡森美辛：首次批准。
Drugs. 2021 May;81(7):875-879. doi: 10.1007/s40265-021-01512-2. Epub 2021 Apr 16.
8
Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy.糖皮质激素在肌肉萎缩症中的作用机制及临床应用。
J Neuromuscul Dis. 2021;8(1):39-52. doi: 10.3233/JND-200556.
9
Viltolarsen: First Approval.维特索伦：首次获批
Drugs. 2020 Jul;80(10):1027-1031. doi: 10.1007/s40265-020-01339-3.
10
Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis.全球杜氏肌营养不良症的流行病学：一项更新的系统评价和荟萃分析。
Orphanet J Rare Dis. 2020 Jun 5;15(1):141. doi: 10.1186/s13023-020-01430-8.
Zotero 插件